カスパーゼ9とSmac/DIABLOの保存されたXIAP相互作用モチーフは,カスパーゼ活性とアポトーシスを調節する
S M Srinivasula1, R Hegde, A Saleh
1Center for Apoptosis Research and the Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Nature
|March 10, 2001
まとめ
X関連アポトーシス阻害タンパク質 (XIAP) はカスパース9と結合し,アポトーシスを阻害する. XIAPに結合するSmacタンパク質は,この相互作用を妨害し,カスパース-9活性を放出することによってアポトーシスを促進します. これは,プログラムされた細胞死における重要な規制メカニズムを明らかにしています.
科学分野:
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- X関連アポトーシス阻害タンパク質 (XIAP) は,アポトーシスの主要な調節体であり,カスパース活性を抑制する.
- Smac (DIABLO) はXIAPを抗し,カスパース抑制を緩和することによってアポトーシスを促進します.
研究 の 目的:
- XIAPがカスパース-9と相互作用し,それを阻害する分子メカニズムを解明する.
- XIAPへのSmac結合が,カスパース9活性とアポトーシスにどのように影響するかを調査する.
主な方法:
- Asp315.5でプロカスペーゼ-9処理を無効化するためにサイト指向型変異を生成する.
- カスパーゼ-9リンカーペプチドのデレーション変異.
- XIAP-caspase-9複合体の形成および阻害アッセイの分析.
主要な成果:
- XIAPは,活性カスパゼ-9-アパフ-1複合体内のカスパゼ-9リンカーペプチドの処理されたアミノ端に結合する.
- リンカー処理やリンカーの削除を防ぐ変異は,XIAP結合と抑制を無効にしました.
- Cascase-9リンカーペプチドとSmacがXIAPのBIR3ドメインに結合することは相互排他的であり,SmacはXIAP-リンカー相互作用を妨害する.
結論:
- XIAPは,処理されたリンカーペプチドに直接結合することによって,カスパース-9の活性を抑制する.
- Smacは,XIAPのBIR3ドメインからcaspase-9リンカーを競争力のある形で異位させることで,caspase-9活性とアポトーシスを強化します.
- これは,アポトーシスを調節するXIAPとの対極ペプチド相互作用を含む保存されたメカニズムを特定します.
関連する概念動画
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...


